epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Cerdelga
    eliglustat

multicheck MultiCheck Results - 0 Interaction

Smiley face Smiley face

Additional Considerations

Smiley face Smiley face eliglustat in Cerdelga

eliglustat is a substrate of CYP2D6 and CYP3A4; drug interaction guidance with CYP450 inhibitors may vary based on CYP2D6 metabolizer status, including extensive metabolizers (EM), intermediate metabolizers (IM), and poor metabolizers (PM)

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information